Messages in brief
AGES launches social media campaign to report adverse reactions
AGES Medical Market Surveillance launches a social media campaign from November 7 - 11, 2016 to increase willingness to report adverse reactions.
Vie…
Review of the web presence of mail order pharmacies 2016
Legal trade in pharmaceutical specialties via the Internet was made possible in Austria in 2015 by an amendment to the Austrian Medicines Act and…
Measures for the safe use of Keppra 100mg/ml Oral Solution
Several cases of accidental overdose associated with Levetiracetam - Oral Solution have been reported throughout Europe. The majority of cases…
Project start VAC2VAC
VAC2VAC (Vaccine batch to vaccine batch comparison by consistency testing) is a research and development project in which new, innovative tests for…
PSUR submissions exclusively via central platform
Changed account data (BIC change)
Please note the changed BIC for transfers to the accounts of the Federal Office for Safety in Health Care (BASG) / AGES Medizinmarktaufsicht. (The…
PSUR repository mandatory in force as of June 13
Due to legal requirements (Reg. (EC) 726/2004, Article 25a), EMA is obliged to set up a database for periodic safety update reports (PSUR) and the…
Pyrrolizidine alkaloids in medicinal products
Recently, pyrrolizidine alkaloids have also been detected in herbal preparations made from plants that do not biosynthesize pyrrolizidine alkaloids.…
Christa Wirthumer-Hoche elected Chairwoman of the EMA Management Board
At the European Medicines Agency (EMA) Management Board meeting in London on March 17, 2016, Christa Wirthumer-Hoche was elected Chair of the EMA…
Electronic application form (eAF)
